GeNeuro’s Therapeutic Domain GeNeuro is developing therapies and
diagnostic tools for diseases associated the expression of the
human endogenous retrovirus MSRV, with a primary focus on
Nervous System diseases: Multiple Sclerosis and Schizophrenia.
Multiple Sclerosis (MS) is an inflammatory disease of the
central nervous system that is characterized by progressive
neurodegeneration in the brain, spinal cord and optic nerves.
The clinical manifestations are muscle weakness, loss of muscle
coordination, pain, and an evolution towards severe disabilities
such as loss of vision, bladder control and paralysis. Cognitive
and psychological problems are frequent. Today, more than 2.5
million people worldwide suffer from MS. Schizophrenia (SCZ) is
a severe and chronic psychiatric disorder. The major clinical
features of the disease are delusions, auditory hallucinations,
thought disorder, social withdrawal, lack of motivation and
cognitive dysfunction. Today, more than 51 million people
worldwide suffer from SCZ. Mult